Home Systematic review and cumulative meta-analysis of the diagnostic accuracy of glial fibrillary acidic protein vs. S100 calcium binding protein B as blood biomarkers in observational studies of patients with mild or moderate acute traumatic brain injury
Article
Licensed
Unlicensed Requires Authentication

Systematic review and cumulative meta-analysis of the diagnostic accuracy of glial fibrillary acidic protein vs. S100 calcium binding protein B as blood biomarkers in observational studies of patients with mild or moderate acute traumatic brain injury

  • Paolo Mastandrea ORCID logo EMAIL logo , Silvia Mengozzi and Sergio Bernardini
Published/Copyright: July 1, 2021

Abstract

Traumatic brain injuries (TBIs) and sports-related concussions (SRCs) are the leading causes of hospitalization and death in subjects <45 years old in the USA and Europe. Some biomarkers (BMs) have been used to reduce unnecessary cranial computed tomography (CCT). In recent years, the astroglial S100 calcium-binding B protein (S100B) has prevented approximately 30% of unnecessary CCTs. Glial fibrillary acidic protein (GFAP) has also been studied in direct comparison with S100B. The aim of our cumulative meta-analysis (cMA) is to compare – in the context of hospital emergency departments or SRC conditions – the differences in diagnostic accuracy (DA), sensitivity (Se) and specificity (Sp) of GFAP and S100B. The main cMA inclusion criterion was the assessment of both BMs in the included subjects since 2010, with blood samples drawn 1–30 h from the suspected TBI or SRC. The risk-of-bias (RoB) score was determined, and both the publication bias (with the Begg, Egger and Duval trim-and-fill tests) and sensitivity (with the box-and-whiskers plot) were analyzed for outliers. Seven studies with 899 subjects and nine observations (samples) were included. The diagnostic odds ratios (dORs) with their prediction intervals (PIs), Se and Sp (analyzed with a hierarchical model to respect the binomial data structure) were assessed, and a random-effects MA and a cMA of the difference in the BMs dOR natural logarithms (logOR(G-S)) between the BMs were performed. The cMA of dOR(G-S) was significant (5.78 (CI 2–16.6)) probably preventing approximately 50% of unnecessary CCTs. Further work is needed to standardize and harmonize GFAP laboratory methods.


Corresponding author: Paolo Mastandrea, Medical Doctor, Clinical Pathologist, Laboratory of Clinical Pathology, Azienda Ospedaliera “s. G. Moscati”, discesa Campanile 52, Mercato San Severino, Avellino, Italy, Phone: +(39) 3483219932, E-mail: .

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Linsenmaier, U, Wirth, S, Kanz, KG, Geier, LL. Imaging minor head injury in emergency radiology: MRI highlights additional intracranial findings after measurement of trauma biomarker S-100B in patients with normal CCT. Br J Radiol 2016;89(1061):20150827. http://dx.doi.org/10.1259/bjr.20150827.10.1259/bjr.20150827Search in Google Scholar

2. Lagerstedt, L, Egea-Guerrero, JJ, Bustamante, A, Rodriguez-Rodriguez, A, El Rahal, A, Quintana-Diaz, M, et al.. Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury. PloS One 2018;13(7):e0200394. https://doi.org/10.1371/journal.pone.0200394.Search in Google Scholar

3. Calcagnile, O, Holmen, A, Chew, M, Unden, J. S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury. Scand J Trauma Resusc Emerg Med 2013;21:52. https://doi.org/10.1186/1757-7241-21-52.Search in Google Scholar

4. Shahim, P, Tegner, Y, Marklund, N, Blennow, K, Zetterberg, H. Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology 2018;90:S1780–88. https://doi.org/10.1212/wnl.0000000000005518.Search in Google Scholar

5. Bazarian, JJ, Blyth, BJ, He, H, Mookerjee, S, Jones, C, Kiechle, K, et al.. Classification accuracy of serum apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan. J Neurotrauma 2013;30:1747–54. https://doi.org/10.1089/neu.2013.2853.Search in Google Scholar

6. Asken, BM, Bauer, RM, DeKosky, ST, Svingos, AM, Hromas, G, Boone, JK, et al.. Concussion basics III: serum biomarker changes following sport-related concussion. Neurology 2018;91:S2133–43. https://doi.org/10.1212/wnl.0000000000006617.Search in Google Scholar

7. Sterne, JAC. Cumulative meta-analysis. In: Palmer, TM, Sterne, JAC, editors. Meta-analysis in Stata. Lakeway drive, College Station, Texas: Stata Press; 2016.Search in Google Scholar

8. Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al.. Meta-analysis of observational studies in epidemiology. A proposal for reporting. MOOSE group. J Am Med Assoc 2000;283:2008–12. https://doi.org/10.1001/jama.283.15.2008.Search in Google Scholar

9. Whiting, PF, Rutjes, AWS, Westwood, ME, Mallet, S, Deeks, JJ, Reitsma, JB, et al.. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.Search in Google Scholar

10. Teasdale, G, Maas, A, Lecky, F, Manley, G, Stocchetti, N, Murray, G. The Glasgow coma scale at 40 years: standing the test of time. Lancet Neurol 2014;13:844–54. https://doi.org/10.1016/s1474-4422(14)70120-6.Search in Google Scholar

11. McCrory, P, Meewisse, W, Dvorak, J, Aubry, M, Bailes, J, Broglio, S, et al.. Consensus statement on concussion in sport – the 5th International Conference on concussion in sport held in Berlin, October 2016. Br J Sports Med 2017;31:838–47.10.1136/bjsports-2017-097699Search in Google Scholar

12. Borenstein, M, Hedges, L, Higgins, J, Rothstein, H. Comprehensive meta analysis version 3. Available from: https://www.Meta-Analysis.com/downloads/MA Manual.pdf.Search in Google Scholar

13. Borenstein, M, Hedges, L, Higgins, J, Rothstein, H, editors. Introduction to meta-analysis. Chichester: Wiley; 2009.10.1002/9780470743386Search in Google Scholar

14. Harbord, RM, Deeks, JJ, Egger, M, Whiting, P, Sterne, JAC. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8:239–51. https://doi.org/10.1093/biostatistics/kxl004.Search in Google Scholar PubMed

15. Harbord, RM, Whiting, P. metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. In: Palmer, TM, Sterne, JAC, editors. Meta-analysis in Stata. Lakeway drive, College Station, Texas: Stata Press; 2016.10.1177/1536867X0900900203Search in Google Scholar

16. Honda, M, Tsuruta, R, Kaneko, T, Kasaoka, S, Yagi, T, Todani, M, et al.. Serum glial fibrillary acidic protein is a higly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma 2010;69:104–9. https://doi.org/10.1097/ta.0b013e3181bbd485.Search in Google Scholar PubMed

17. Welch, RD, Ayaz, SI, Lewis, LM, Unden, J, Chen, JY, Mika, VH, et al.. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma 2016;33:203–14. https://doi.org/10.1089/neu.2015.4149.Search in Google Scholar PubMed PubMed Central

18. Lewis, LM, Schloemann, DT, Papa, L, Fucetola, RP, Bazarian, J, Lindburg, M, et al.. Utility of serum biomarkers in the diagnosis and stratification of mild traumatic brain injury. Acad Emerg Med 2017;24:710–20. https://doi.org/10.1111/acem.13174.Search in Google Scholar PubMed

19. Mahan, MY, Thorpe, M, Ahmadi, A, Abdallah, T, Casey, H, Sturtevant, D, et al.. Glial fibrillary acidic protein outperforms S100 calcium-binding protein B and ubiquitin C-terminal hydrolase L1 as predictor for positive computed tomography of the head in trauma subjects. World Neurosurg 2019;128:S434–44. https://doi.org/10.1016/j.wneu.2019.04.170.Search in Google Scholar PubMed

20. Posti, JP, Takala, RSK, Lagerstedt, L, Dickens, AM, Hossain, I, Mohammadian, M, et al.. Correlation of blood biomarkers and biomarker panels with traumatic findings on computed tomography after traumatic brain injury. J Neurotrauma 2019;36:2178–89. https://doi.org/10.1089/neu.2018.6254.Search in Google Scholar PubMed PubMed Central

21. Unden, J, Ingebrigtsen, T, Romner, B, for the Scandinavian Neurotrauma Committee (SNC). Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med 2013;11:50. https://doi.org/10.1186/1741-7015-11-50.Search in Google Scholar PubMed PubMed Central

22. Jagoda, AS, Bazarian, JJ, Bruns, JJJr, Cantrill, SV, Gean, AD, Howard, PK, et al.. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2008;52:714–48. https://doi.org/10.1016/j.annemergmed.2008.08.021.Search in Google Scholar PubMed

23. Barbosa, RR, Jawa, R, Watters, JM, Knight, JC, Kerwin, AJ, Winston, ES, et al.. Evaluation and management of mild traumatic brain injury: an Eastern association for the surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73:S307–14. https://doi.org/10.1097/ta.0b013e3182701885.Search in Google Scholar PubMed

24. Silverberg, ND, Iaccarino, MA, Panenka, WJ, Iverson, GL, McCulloch, KL, Dams-O’Connor, K, et al.. Management of concussion and mild traumatic brain injury: a synthesis of practice guidelines. Arch Phys Med Rehabil 2020;101:382–93. https://doi.org/10.1016/j.apmr.2019.10.179.Search in Google Scholar PubMed

25. Huie, JR, Diaz-Arrastia, R, Yue, JK, Sorani, MD, Puccio, AM, Okonkwo, DO, et al.. Testing a multivariate proteomic panek for traumatic brain injury biomarker discovery: a TRACK-TBI pilot study. J Neurotrauma 2019;36:100–10. https://doi.org/10.1089/neu.2017.5449.Search in Google Scholar PubMed PubMed Central

26. Borenstein, M. Mistakes in using the I2 statistic. In: Borenstein, M, editor. Common mistakes in meta-analysis. Englewood: Biostat Inc.; 2019.Search in Google Scholar

27. Gilquin, B, Cannon, BR, Hubstenberger, A, Moulouel, B, Falk, E, Merle, N, et al.. The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A. Med Cell Biol 2010;30:2724–36. https://doi.org/10.1128/mcb.01468-09.Search in Google Scholar

28. Weinstein, DE, Shelanski, ML, Liem, RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 1991;112:1205–13. https://doi.org/10.1083/jcb.112.6.1205.Search in Google Scholar PubMed PubMed Central

29. Ohrt-Nissen, S, Friis-Hansen, L, Dahl, B, Stensballe, J, Romner, B, Rasmussen, LS. How does extracerebral trauma affect the clinical value of S100B measurements?. Emerg Med J 2011;28:941–4. https://doi.org/10.1136/emj.2010.091363.Search in Google Scholar PubMed PubMed Central

30. Astrand, R, Unden, J. Clinical use of the calcium-binding S100B protein, a biomarker for head injury. Methods Mol Biol 2019;1929:679–90. https://doi.org/10.1007/978-1-4939-9030-6_42.Search in Google Scholar PubMed

31. Hasselblatt, M, Mooren, FC, von Ahsen, N, Keyvani, K, Fromme, A, Schwarze-Eicker, K, et al.. Serum S100 beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 2004;62:1634–36. https://doi.org/10.1212/01.wnl.0000123092.97047.b1.Search in Google Scholar PubMed

32. Zetterberg, H, Smith, DH, Blennow, K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol 2013;9:201–10. https://doi.org/10.1038/nrneurol.2013.9.Search in Google Scholar PubMed PubMed Central

33. Stefanovic, B, Duric, O, Stankovic, S, Mijatovic, S, Doklestic, K, Stefanovic, B, et al.. Elevated serum protein S100B and neuron specific enolase values as predictors of early neurologic outcome after traumatic brain injury. J Med Biochem 2017;36:314–21.10.1515/jomb-2017-0018Search in Google Scholar PubMed PubMed Central

34. Laribi, S, Kansao, J, Borderie, D, Collet, C, Deschamps, P, Ababsa, R, et al.. S100B blood level measurement to exclude cerebral lesions after minor head injury-the multicenter STIC-S100 French study. Clin Chem Lab Med 2014;52:527–36. https://doi.org/10.1515/cclm-2013-0621.Search in Google Scholar PubMed

35. Bouvier, D, Fournier, M, Dauphin, JB, Amat, F, Ughetto, S, Labbé, A, et al.. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clin Chem 2012;58:1116–22. https://doi.org/10.1373/clinchem.2011.180828.Search in Google Scholar PubMed

36. Calcagnile, O, Anell, A, Unden, J. The addition of S100B to guidelines for management of mild head injury is potentially cost saving. BMC Neurol 2016. https://doi.org/10.1186/s12883-016-0723-z.Search in Google Scholar PubMed PubMed Central

37. Allouchery, G, Moustafa, F, Roubin, J, Pereira, B, Schmidt, J, Raconnat, J, et al.. Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients. Clin Chem Lab Med 2018;56:1897–904. https://doi.org/10.1515/cclm-2018-0471.Search in Google Scholar PubMed

38. Lippi, G, Cervellin, G. Diagnostic approach to the mild head trauma of the adult in emergency medicine: between biomarkers and imaging. Recenti Prog Med 2013;104:120–32. https://doi.org/10.1701/1255.13861.Search in Google Scholar PubMed

39. Diaz-Arrastia, R, Wang, KKW, Papa, L, Sorani, MD, Yue, JK, Puccio, AM, et al.. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 2014;31:19–25. https://doi.org/10.1089/neu.2013.3040.Search in Google Scholar PubMed PubMed Central

40. Tomita, K, Nakada, TA, Oshima, T, Motoshima, T, Kawaguchi, R, Oda, S. Tau protein as a diagnostic marker for diffuse axonal injury. PLoS One 2019. https://doi.org/10.1371/journal.pone.0214381.Search in Google Scholar PubMed PubMed Central


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/dx-2021-0006)


Received: 2021-01-11
Accepted: 2021-05-17
Published Online: 2021-07-01

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. From Camille Nούς to Apollonian and the Dionysian scientists
  4. Review
  5. The role of D-dimer in periprosthetic joint infection: a systematic review and meta-analysis
  6. Mini Reviews
  7. Updated picture of SARS-CoV-2 variants and mutations
  8. Systematic review and cumulative meta-analysis of the diagnostic accuracy of glial fibrillary acidic protein vs. S100 calcium binding protein B as blood biomarkers in observational studies of patients with mild or moderate acute traumatic brain injury
  9. Opinion Papers
  10. The 6C model for accurately capturing the patient’s medical history
  11. Webside manner: maskless communication
  12. Original Articles
  13. Ways that nurse practitioner students self-explain during diagnostic reasoning
  14. Diagnostic reasoning: relationships among expertise, accuracy, and ways that nurse practitioner students self-explain
  15. Perspectives on the current state of pre-clerkship clinical reasoning instruction in United States medical schools: a survey of clinical skills course directors
  16. Use of a structured approach and virtual simulation practice to improve diagnostic reasoning
  17. Analyzing diagnostic errors in the acute setting: a process-driven approach
  18. Morning report goes virtual: learner experiences in a virtual, case-based diagnostic reasoning conference
  19. Stroke hospitalization after misdiagnosis of “benign dizziness” is lower in specialty care than general practice: a population-based cohort analysis of missed stroke using SPADE methods
  20. Discrepancy between emergency department admission diagnosis and hospital discharge diagnosis and its impact on length of stay, up-triage to the intensive care unit, and mortality
  21. Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework
  22. Short Communication
  23. Characterizing the relationship between diagnostic intensity and quality of care
  24. Case Reports – Lessons in Clinical Reasoning
  25. Lessons in clinical reasoning ‒ pitfalls, myths, and pearls: a case of confusion, disequilibrium, and “picking at the air”
  26. Hickam’s dictum, Occam’s razor, and Crabtree’s bludgeon: a case of renal failure and a clavicular mass
  27. Letters to the Editor
  28. Three learning concepts to improve diagnosis and enhance the practice of medicine
  29. Distributed cognition: a framework for conceptualizing telediagnosis in teams
  30. Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dx-2021-0006/html
Scroll to top button